PMC:7445716 / 81915-82843 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T770","span":{"begin":156,"end":164},"obj":"Disease"},{"id":"T771","span":{"begin":176,"end":179},"obj":"Disease"},{"id":"T772","span":{"begin":337,"end":345},"obj":"Disease"},{"id":"T773","span":{"begin":482,"end":490},"obj":"Disease"},{"id":"T774","span":{"begin":495,"end":498},"obj":"Disease"},{"id":"T775","span":{"begin":624,"end":628},"obj":"Disease"},{"id":"T777","span":{"begin":790,"end":793},"obj":"Disease"},{"id":"T778","span":{"begin":873,"end":876},"obj":"Disease"},{"id":"T779","span":{"begin":883,"end":891},"obj":"Disease"}],"attributes":[{"id":"A770","pred":"mondo_id","subj":"T770","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A771","pred":"mondo_id","subj":"T771","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A772","pred":"mondo_id","subj":"T772","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A773","pred":"mondo_id","subj":"T773","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A774","pred":"mondo_id","subj":"T774","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A775","pred":"mondo_id","subj":"T775","obj":"http://purl.obolibrary.org/obo/MONDO_0006702"},{"id":"A776","pred":"mondo_id","subj":"T775","obj":"http://purl.obolibrary.org/obo/MONDO_0007691"},{"id":"A777","pred":"mondo_id","subj":"T777","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A778","pred":"mondo_id","subj":"T778","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A779","pred":"mondo_id","subj":"T779","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Major strengths of our review are the inclusion of a high number of patients, together with an in-depth analysis of the clinical and diagnostic features of COVID-19-associated GBS. We are aware that selection bias might have occurred, given that most reported cases to date have been described mostly in Europe (47 out of 73) and during COVID-19 highest spreading. Therefore, future extensive epidemiological studies are necessary to ascertain the nature of the association between COVID-19 and GBS (causal or coincidental). Moreover, we cannot exclude the possibility that at least some of the cases represent instances of CIDP, given the frequent absence of a follow-up longer than 2 months. On another issue, the low but possible evidence of an epidemiological link between vaccines and GBS development [57, 58] should aware the clinicians of the possible occurrence of GBS after COVID-19 vaccination in the long-term future."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T723","span":{"begin":51,"end":52},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T724","span":{"begin":660,"end":661},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Major strengths of our review are the inclusion of a high number of patients, together with an in-depth analysis of the clinical and diagnostic features of COVID-19-associated GBS. We are aware that selection bias might have occurred, given that most reported cases to date have been described mostly in Europe (47 out of 73) and during COVID-19 highest spreading. Therefore, future extensive epidemiological studies are necessary to ascertain the nature of the association between COVID-19 and GBS (causal or coincidental). Moreover, we cannot exclude the possibility that at least some of the cases represent instances of CIDP, given the frequent absence of a follow-up longer than 2 months. On another issue, the low but possible evidence of an epidemiological link between vaccines and GBS development [57, 58] should aware the clinicians of the possible occurrence of GBS after COVID-19 vaccination in the long-term future."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1252","span":{"begin":67,"end":75},"obj":"Species"},{"id":"1253","span":{"begin":155,"end":163},"obj":"Disease"},{"id":"1254","span":{"begin":336,"end":344},"obj":"Disease"},{"id":"1255","span":{"begin":481,"end":489},"obj":"Disease"},{"id":"1256","span":{"begin":623,"end":627},"obj":"Disease"},{"id":"1257","span":{"begin":882,"end":890},"obj":"Disease"}],"attributes":[{"id":"A1252","pred":"tao:has_database_id","subj":"1252","obj":"Tax:9606"},{"id":"A1253","pred":"tao:has_database_id","subj":"1253","obj":"MESH:C000657245"},{"id":"A1254","pred":"tao:has_database_id","subj":"1254","obj":"MESH:C000657245"},{"id":"A1255","pred":"tao:has_database_id","subj":"1255","obj":"MESH:C000657245"},{"id":"A1256","pred":"tao:has_database_id","subj":"1256","obj":"MESH:D020277"},{"id":"A1257","pred":"tao:has_database_id","subj":"1257","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Major strengths of our review are the inclusion of a high number of patients, together with an in-depth analysis of the clinical and diagnostic features of COVID-19-associated GBS. We are aware that selection bias might have occurred, given that most reported cases to date have been described mostly in Europe (47 out of 73) and during COVID-19 highest spreading. Therefore, future extensive epidemiological studies are necessary to ascertain the nature of the association between COVID-19 and GBS (causal or coincidental). Moreover, we cannot exclude the possibility that at least some of the cases represent instances of CIDP, given the frequent absence of a follow-up longer than 2 months. On another issue, the low but possible evidence of an epidemiological link between vaccines and GBS development [57, 58] should aware the clinicians of the possible occurrence of GBS after COVID-19 vaccination in the long-term future."}

{"project":"LitCovid-sentences","denotations":[{"id":"T481","span":{"begin":0,"end":180},"obj":"Sentence"},{"id":"T482","span":{"begin":181,"end":364},"obj":"Sentence"},{"id":"T483","span":{"begin":365,"end":524},"obj":"Sentence"},{"id":"T484","span":{"begin":525,"end":693},"obj":"Sentence"},{"id":"T485","span":{"begin":694,"end":928},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Major strengths of our review are the inclusion of a high number of patients, together with an in-depth analysis of the clinical and diagnostic features of COVID-19-associated GBS. We are aware that selection bias might have occurred, given that most reported cases to date have been described mostly in Europe (47 out of 73) and during COVID-19 highest spreading. Therefore, future extensive epidemiological studies are necessary to ascertain the nature of the association between COVID-19 and GBS (causal or coincidental). Moreover, we cannot exclude the possibility that at least some of the cases represent instances of CIDP, given the frequent absence of a follow-up longer than 2 months. On another issue, the low but possible evidence of an epidemiological link between vaccines and GBS development [57, 58] should aware the clinicians of the possible occurrence of GBS after COVID-19 vaccination in the long-term future."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T1209","span":{"begin":156,"end":164},"obj":"SP_7"},{"id":"T1210","span":{"begin":337,"end":345},"obj":"SP_7"},{"id":"T1211","span":{"begin":482,"end":490},"obj":"SP_7"},{"id":"T1212","span":{"begin":883,"end":891},"obj":"SP_7"},{"id":"T52689","span":{"begin":156,"end":164},"obj":"SP_7"},{"id":"T93654","span":{"begin":337,"end":345},"obj":"SP_7"},{"id":"T6953","span":{"begin":482,"end":490},"obj":"SP_7"},{"id":"T26779","span":{"begin":883,"end":891},"obj":"SP_7"}],"text":"Major strengths of our review are the inclusion of a high number of patients, together with an in-depth analysis of the clinical and diagnostic features of COVID-19-associated GBS. We are aware that selection bias might have occurred, given that most reported cases to date have been described mostly in Europe (47 out of 73) and during COVID-19 highest spreading. Therefore, future extensive epidemiological studies are necessary to ascertain the nature of the association between COVID-19 and GBS (causal or coincidental). Moreover, we cannot exclude the possibility that at least some of the cases represent instances of CIDP, given the frequent absence of a follow-up longer than 2 months. On another issue, the low but possible evidence of an epidemiological link between vaccines and GBS development [57, 58] should aware the clinicians of the possible occurrence of GBS after COVID-19 vaccination in the long-term future."}

{"project":"2_test","denotations":[{"id":"32840686-31541214-63205875","span":{"begin":806,"end":808},"obj":"31541214"},{"id":"32840686-26948435-63205876","span":{"begin":810,"end":812},"obj":"26948435"}],"text":"Major strengths of our review are the inclusion of a high number of patients, together with an in-depth analysis of the clinical and diagnostic features of COVID-19-associated GBS. We are aware that selection bias might have occurred, given that most reported cases to date have been described mostly in Europe (47 out of 73) and during COVID-19 highest spreading. Therefore, future extensive epidemiological studies are necessary to ascertain the nature of the association between COVID-19 and GBS (causal or coincidental). Moreover, we cannot exclude the possibility that at least some of the cases represent instances of CIDP, given the frequent absence of a follow-up longer than 2 months. On another issue, the low but possible evidence of an epidemiological link between vaccines and GBS development [57, 58] should aware the clinicians of the possible occurrence of GBS after COVID-19 vaccination in the long-term future."}